Advertisement

Healthcare Governance and Climate Change Adaptation: A Pharmaceutical Industry Perspective

  • Md Khalid Hossain
  • Sharif N. As-Saber
Chapter

Abstract

The 4th assessment report of the Intergovernmental Panel on Climate Change (IPCC) concludes that ‘the global burden of disease and premature deaths’ are somewhat contributed by climate change (IPCC, Introduction to the working group II – fourth assessment report. In: Parry ML, Canziani OF, Palutikof JP, van der Linden PJ, Hanson CE (eds) Climate change 2007: impacts, adaptation and vulnerability. Cambridge University Press, Cambridge, pp 1–6, 2007). The extant literature and scientific evidence on climate change and public health also suggest that climate change could create one of the biggest challenges to public health and its future governance. This does not only have profound impact on public sector health services but also poses significant threats to private sector health service providers. One of the private sector establishments that tend to become directly affected by climate change is the pharmaceutical industry. Given the scenario of uncertainty and risk associated with climate change, this industry appears to be in a unique albeit intricate situation as it faces both risks and opportunities as a consequence of climate change. As climate change adaptation entails both risk aversion and opportunity utilisation, it may, therefore, be considered useful to study the pharmaceutical industry in relation to its exposure to climate change and subsequent adaptation measures. Given the paramount importance of climate change adaptation by the pharmaceutical industry and its social and environmental implications, the issue of governance becomes an indispensible part of any such study. Following a scrutiny of the extant literature and recent scientific evidence on climate change, this chapter aims to present climate change adaptation strategies adopted by the pharmaceutical industry. The role of government in managing or moderating these strategies is also considered.

Keywords

Climate Change Corporate Social Responsibility Pharmaceutical Industry Risk Aversion Climate Change Impact 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Accenture, GlaxoSmithKline & the Smith School of Enterprise and the Environment (2011) Climate change and health: framing the issue. Accenture, New YorkGoogle Scholar
  2. ADB (Asian Development Bank) (2011) Accounting for health impacts of climate change. Asian Development Bank, Mandaluyong CityGoogle Scholar
  3. Ahmed AU (2006) Bangladesh: climate change impacts and vulnerability: a synthesis. Climate Change Cell, Department of Environment, DhakaGoogle Scholar
  4. As-Saber SN (2009) Rediscovering the role of governments in the present era of governance. In: As-Saber SN, Singh A, Ahmad R, Jalal J (eds) Strengthening governance in the Asia Pacific: myths, realities and paradoxes. McMillan, New Delhi, pp 1–16Google Scholar
  5. Atkins P (1999) Chlorofluorocarbon to hydrofluoroalkane formulations: an industry perspective. J Allergy Clin Immunol 104(6):268–270CrossRefGoogle Scholar
  6. Babovic S, Wasan KM (2011) Impact of the trade-related aspects of intellectual property rights (TRIPS) agreement on India as a supplier of generic antiretrovirals. J Pharm Sci 100(3):816–821CrossRefGoogle Scholar
  7. Berkhout F, Hertin J, Gann DM (2006) Learning to adapt: organizational adaptation to climate change impacts. Clim Chang 78(1):135–156CrossRefGoogle Scholar
  8. Binns C, Low WY (2011) Climate change: the greatest equity issue in public health. Asia Pac J Public Health 23(2, supplement):5S–6SCrossRefGoogle Scholar
  9. Chaudhuri S, Goldberg PK, Jia P (2006) Estimating the effects of global patent protection in pharmaceuticals: a case study of quinolones in India. Am Econ Rev 96(5):1477–1514CrossRefGoogle Scholar
  10. Cogan D, Good M, Kantor G, McAteer E (2008) Corporate governance and climate change: consumer and technology companies. Ceres, Inc., BostonGoogle Scholar
  11. Confalonieri U, Menne B, Akhtar R, Ebi KL, Hauengue M, Kovats RS, Revich B, Woodward A (2007) Human health. In: Parry ML, Canziani OF, Palutikof JP, van der Linden PJ, Hanson CE (eds) Climate change 2007: impacts, adaptation and vulnerability. Cambridge University Press, Cambridge, pp 391–431Google Scholar
  12. Connor SJ, Omumbo J, Green C, DaSilva J, Mantilla G, Delacollette C, Hales S, Rogers D, Thomson M (2010) Health and climate: needs. Procedia Environ Sci 1:27–36CrossRefGoogle Scholar
  13. Costello A, Abbas M, Allen A, Ball S, Bell S, Bellamy R, Friel S, Groce N, Johnson A, Kett M, Lee M, Levy C, Maslin M, McCoy D, McGuire B, Montgomery H, Napier D, Pagel C, Patel J, Antonio J, de Oliveira P, Redclift N, Rees H, Rogger D, Scott J, Stephenson J, Twigg J, Wolff J, Patterson C (2009) Managing the health effects of climate change. Lancet 373:1693–1733CrossRefGoogle Scholar
  14. Epstein PR (2005) Climate change and human health. N Engl J Med 353(14):1433–1436CrossRefGoogle Scholar
  15. Fidler DP (2010) The challenges of global health governance. Council on Foreign Relations, New YorkGoogle Scholar
  16. Gardiner D, Anderson M, Schlesinger R, Gorte JF, Zeller D (2007) Climate risk disclosure by the S&P 500. Ceres, Inc., BostonGoogle Scholar
  17. Greve J (2008) Healthcare in developing countries and the role of business: a global governance framework to enhance the accountability of pharmaceutical companies. Corp Gov 8(4):490–505CrossRefGoogle Scholar
  18. Grover A, Citro B (2011) India: access to affordable drugs and the right to health. Lancet 377(9770):976–977CrossRefGoogle Scholar
  19. Hanna EG, Kjellstrom T, Bennett C, Dear K (2011a) Climate change and rising heat: population health implications for working people in Australia. Asia Pac J Public Health 23(2, supplement):14S–26SCrossRefGoogle Scholar
  20. Hanna EG, Spickett JT, Spickett JT (2011b) Climate change and human health: building Australia’s adaptation capacity. Asia Pac J Public Health 23(2, supplement):7S–13SCrossRefGoogle Scholar
  21. Husain T, Chaudhary JR (2008) Human health risk assessment due to global warming: a case study of the Gulf countries. Int J Environ Res Public Health 5:204–212CrossRefGoogle Scholar
  22. IIED (International Institute for Environment and Development) & Irish Aid (2011) Health: mainstreaming environment and climate change. IIED, LondonGoogle Scholar
  23. IPCC (Intergovernmental panel on Climate Change) (2007) Introduction to the working group II – fourth assessment report. In: Parry ML, Canziani OF, Palutikof JP, van der Linden PJ, Hanson CE (eds) Climate change 2007: impacts, adaptation and vulnerability. Cambridge University Press, Cambridge, pp 1–6Google Scholar
  24. Kaufmann D, Kraay A, Mastruzzi M (2009) Governance matters VIII: aggregate and individual governance indicators 1996–2008. World Bank Publication, Washington, DCGoogle Scholar
  25. King MD, Sarria P, Moss DJ, Numark NJ (2004) U.S. Business actions to address climate change: case studies of five industry sector. Green Business Network, Washington, DCGoogle Scholar
  26. Kolk A, Pinkse J (2004) Market strategies for climate change. Eur Manag J 22(3):304–314CrossRefGoogle Scholar
  27. Kolk A, Pinkse J (2005) Business responses to climate change: identifying emergent strategies. Calif Manage Rev 47(3):6–20CrossRefGoogle Scholar
  28. Kolk A, Pinkse J (2008) A perspective on multinational enterprises and climate change: learning from “an inconvenient truth”? J Int Bus Stud 39(8):1359–1378CrossRefGoogle Scholar
  29. KPMG International (2008) Climate changes your business: KPMG’s review of the business risks and economic impacts at sector level. Reijnen Offset, AmsterdamGoogle Scholar
  30. Leary NA (1999) A framework for benefit-cost analysis of adaptation to climate change and climate variability. Mitig Adapt Strat Glob Chang 4(3–4):307–318CrossRefGoogle Scholar
  31. Linnenluecke M, Griffiths A (2010) Beyond adaptation: resilience for business in light of climate change and weather extremes. Bus Soc 49(3):477–511CrossRefGoogle Scholar
  32. Llewellyn J (2007) The business of climate change: challenges and opportunities. Lehman Brothers, New YorkGoogle Scholar
  33. Lovell SA (2011) Health governance and the impact of climate change on Pacific small Island developing states. Int Hum Dimen Program (IHDP) Update 1:50–55Google Scholar
  34. Malhotra P (2008) The impact of TRIPS on innovation and exports: a case study of the pharmaceutical industry in India. Indian J Med Ethics 5(2):61–65Google Scholar
  35. Marques A, Nunes ML, Moore SK, Strom MS (2010) Climate change and seafood safety: human health implications. Food Res Int 43:1766–1779CrossRefGoogle Scholar
  36. McMichael AJ, Neira M, Bertollini R, Campbell-Lendrum D, Hales S (2009) Climate change: A time of need and opportunity for the health sector. Lancet 374:2123–2125CrossRefGoogle Scholar
  37. Mitchell SM, Shortell SM (2000) The governance and management of effective community health partnerships: a typology for research, policy, and practice. Milbank Q 78(2):241–289CrossRefGoogle Scholar
  38. Pang T, Daulaire N, Keusch G, Leke R, Piot P, Reddy S, Rys A, Szlezak N (2010) The new age of global health governance holds promise. Nat Med 16(11):1181CrossRefGoogle Scholar
  39. Patz JA, Epstein PR, Burke TA, Balbus JM (1996) Global climate change and emerging infectious diseases. J Am Med Assoc 275(3):217–223CrossRefGoogle Scholar
  40. Porter ME, Reinhardt FL (2007) A strategic approach to climate. Harv Bus Rev 85(10):22–26Google Scholar
  41. Ruggie JG (2004) Reconstituting the global public domain: issues, actors, and practices. Eur J Int Relations 10(4):499–531CrossRefGoogle Scholar
  42. Salt JE (2003) Health climate change: implications for the pharmaceutical sector. Annu Rep Med Chem 38:375–382CrossRefGoogle Scholar
  43. Satyanarayana K, Srivastava S (2007) Poverty, health & intellectual property rights with special reference to India. Indian J Med Res 126(4):390–406Google Scholar
  44. Shukla N, Sangal T (2009) Generic drug industry in India: the counterfeit spin. J Intellect Property Rights 14(3):236–240Google Scholar
  45. Siddiqi S, Masud TI, Nishtar S, Sabri B (2006) Framework for assessing health governance in developing countries: gateway to good governance. Presentation made at Health System Metrics Technical Meeting, 28–29 Sept 2006, Montreux-Glion, SwitzerlandGoogle Scholar
  46. Smit B, Burton I, Klein RJT, Wandel J (2000) An anatomy of adaptation to climate change and variability. Climate Change 45(1):223–251CrossRefGoogle Scholar
  47. Sturchio JL (2008) Business engagement in public programs: the pharmaceutical industry’s contribution to public health and the millennium development goals. Corp Gov 8(4):482–489CrossRefGoogle Scholar
  48. UNDP (United Nations Development Program) (2007) Fighting climate change: human solidarity in a divided world. Human Development Report 2007/2008. United Nations Publication, New YorkGoogle Scholar
  49. Wachira C, Ruger JP (2011) National poverty reduction strategies and HIV/AIDS governance in Malawi: a preliminary study of shared health governance. Soc Sci Med 72(12):1956–1964CrossRefGoogle Scholar
  50. World Bank (2011) Healthy partnerships: how governments can engage the private sector to improve health in Africa. World Bank, Washington, DCGoogle Scholar

Copyright information

© Springer India 2013

Authors and Affiliations

  1. 1.School of ManagementRMIT UniversityMelbourneAustralia

Personalised recommendations